HopeStage
Back to all studies
RecruitingNCT06218706

Active or sham focused ultrasound for treatment-resistant opioid use

About this title

LIFU for Treatment for Refractory Opioid Use Disorder

Read the official source — NCT06218706
Device studyAges 22–60United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: 22 years to 60 years.

Listed locations
MorgantownSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: May 9, 2024
Recruitment status
Recruiting
Enrollment listed in the registry
34
Sponsor
Ali Rezai
Sponsor type
Unknown or unclear
Study type
Device
Intervention type
Device
Locations
United States
Age range
From 22 Years to 60 Years
Official registry ID
NCT06218706
Official title
Show the full official title

A Randomized, Sham-Controlled Trial Investigating Low Intensity Focused Ultrasound as a Novel Treatment for Refractory Opioid Use Disorder

Recruitment & locations

Currently recruiting

Morgantown

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Ali Rezai.

Who can participate?

Listed age limits: 22 years to 60 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies